Advancing the assessment and treatment of mucositis.
Oral mucositis is inflammation of the mucosal oral and oropharyngeal tissues. It is a troubling and difficult side effect of cancer treatment. This program discussed the biology of oral mucositis and its effect on cancer therapy outcomes. Speakers covered the treatment goals for patients with oral mucositis and reviewed treatment options and related nursing implications.
D000970:Antineoplastic Agents / Q000009:adverse effects; D017281:Cost of Illness; D004338:Drug Combinations; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use; D009061:Mouth Mucosa; D009730:Nursing Assessment / Q000379:methods*; D009859:Oncology Nursing / Q000379:methods*; D011205:Povidone / Q000627:therapeutic use; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D013280:Stomatitis / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology / Q000628:therapy*
D000970:Antineoplastic Agents; D004338:Drug Combinations; C439265:Gelclair; D006820:Hyaluronic Acid; D011205:Povidone